Neuberger Berman Group
ALNY icon

Neuberger Berman Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.3M Buy
99,044
+605
+0.6% +$197K 0.02% 533
2025
Q1
$26.6M Sell
98,439
-11,269
-10% -$3.04M 0.02% 559
2024
Q4
$25.8M Buy
109,708
+3,511
+3% +$826K 0.02% 596
2024
Q3
$29.2M Buy
106,197
+10,789
+11% +$2.97M 0.02% 562
2024
Q2
$23.2M Buy
95,408
+4,058
+4% +$986K 0.02% 604
2024
Q1
$13.7M Buy
91,350
+19,686
+27% +$2.94M 0.01% 740
2023
Q4
$13.7M Sell
71,664
-18,176
-20% -$3.48M 0.01% 712
2023
Q3
$15.9M Sell
89,840
-9
-0% -$1.59K 0.01% 642
2023
Q2
$17.1M Buy
89,849
+397
+0.4% +$75.4K 0.02% 640
2023
Q1
$17.9M Buy
89,452
+28,682
+47% +$5.75M 0.02% 644
2022
Q4
$14.4M Buy
60,770
+55,952
+1,161% +$13.3M 0.01% 680
2022
Q3
$965K Buy
4,818
+123
+3% +$24.6K ﹤0.01% 1269
2022
Q2
$685K Sell
4,695
-1,590
-25% -$232K ﹤0.01% 1400
2022
Q1
$1.03M Buy
6,285
+2,584
+70% +$422K ﹤0.01% 1338
2021
Q4
$553K Buy
+3,701
New +$553K ﹤0.01% 1515
2019
Q1
Sell
-2,871
Closed -$209K 1506
2018
Q4
$209K Hold
2,871
﹤0.01% 1481
2018
Q3
$251K Sell
2,871
-438
-13% -$38.3K ﹤0.01% 1482
2018
Q2
$326K Buy
3,309
+643
+24% +$63.3K ﹤0.01% 1484
2018
Q1
$318K Hold
2,666
﹤0.01% 1449
2017
Q4
$339K Hold
2,666
﹤0.01% 1506
2017
Q3
$313K Sell
2,666
-207
-7% -$24.3K ﹤0.01% 1397
2017
Q2
$229K Buy
+2,873
New +$229K ﹤0.01% 1475
2016
Q4
Sell
-3,031
Closed -$205K 1579
2016
Q3
$205K Buy
+3,031
New +$205K ﹤0.01% 1511
2015
Q2
Sell
-4,500
Closed -$470K 1559
2015
Q1
$470K Hold
4,500
﹤0.01% 1350
2014
Q4
$436K Hold
4,500
﹤0.01% 1379
2014
Q3
$351K Buy
+4,500
New +$351K ﹤0.01% 1424
2013
Q4
Sell
-22,900
Closed -$1.47M 1612
2013
Q3
$1.47M Buy
+22,900
New +$1.47M ﹤0.01% 1123